Ergometric exercise testing and sensitivity of cyclic guanosine 3',5'-monophosphate (cGMP) in diagnosing asymptomatic left ventricular dysfunction.

Documenti analoghi

• Natriuretic peptides and cyclic guanosine 3',5'-monophosphate in asymptomatic and symptomatic left ventricular dysfunction.
  di: Friedl, W., et al.
  Pubblicazione: (1996)
• Saxagliptin and Tadalafil Differentially Alter Cyclic Guanosine Monophosphate (cGMP) Signaling and Left Ventricular Function in Aortic‐Banded Mini‐Swine
  di: Hiemstra, Jessica A., et al.
  Pubblicazione: (2016)
• Inhibition of PDE5A1 guanosine cyclic monophosphate (cGMP) hydrolysing activity by sildenafil analogues that inhibit cellular cGMP efflux
  di: Subbotina, Anna, et al.
  Pubblicazione: (2017)
• Alterations in the Cerebellar (Phospho)Proteome of a Cyclic Guanosine Monophosphate (cGMP)-dependent Protein Kinase Knockout Mouse
  di: Corradini, Eleonora, et al.
  Pubblicazione: (2014)
• Increased guanylate cyclase activity is associated with an increase in cyclic guanosine 3',5'-monophosphate in left ventricular hypertrophy.
  di: Sadoff, J D, et al.
  Pubblicazione: (1996)